COVID 19 all comers | COVID-19 mild to moderate | ||
COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | |
Renin-angiotensin-system-acting agents | |||
angiotensin receptor blockers (ARBs) | Nouri-Vaskeh | ||
losartan | University of Minnesota | ||
discontinuation of ACEI/ARB | Lopes ... |